Skip to content

Diagnostic accuracy and reliability of the Toshiba rapid influenza diagnostic kit compared to the quickNavi diagnostic kit and polymerase chain reaction (PCR) test

In patients with flu symptoms, does the Toshiba rapid influenza diagnostic kit, compared to the Quick-navi diagnostic kit and PCR test give accurate & reliable diagnosis of influenza

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614001049662
Acronym
SMART ID
Enrollment
205
Registered
2014-10-01
Start date
2014-10-07
Completion date
2015-10-29
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Toshiba medical systems have developed a new rapid diagnostic test device kit for influenza using new technology from current rapid tests available. The device is able to detect influenza virus in a much smaller sample and provide a result in around ten minutes. It will be compared with the Denka Seiken QuickNavi POCT device already marketed for use overseas for accuracy of results however neither device will be used to make a diagnosis. The diagnosis will be made from the accepted RT-PCR (separation culture) test. Participants will have 3 samples taken from either the nose or throat. 1sample for the culture and 1 sample for each device.

Interventions

Analysis of Toshiba's rapid diagnosis of nasal or throat swabs to detect Influenza virus A or B by new point of care testing (POCT) device using optical attenuation caused by reflection or scattering at formed immune complexes, the accuracy of results will be compared with an existing rapid influenza POCT device. Diagnosis of influenza will only be made from the sample analysed by the Australian accepted standard RT-PCR test. Participants will provide 3 samples in total at the one visit from ei

Analysis of Toshiba's rapid diagnosis of nasal or throat swabs to detect Influenza virus A or B by new point of care testing (POCT) device using optical attenuation caused by reflection or scattering at formed immune complexes, the accuracy of results will be compared with an existing rapid influenza POCT device. Diagnosis of influenza will only be made from the sample analysed by the Australian accepted standard RT-PCR test. Participants will provide 3 samples in total at the one visit from either nose or throat. One for each of the devices and one for the RT-PCR test Participants will be asked about the onset of their influenza symptoms and what those symptoms are and have their temperature taken.

Sponsors

South Australian Health & Medical Research Insitute
Lead SponsorOther

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No

Inclusion criteria

Consenting adults or children (parent, guardian, or legal representative providing consent) presenting with influenza symptoms in whom there is a physician assessment of suspected influenza. Persons willing to participate and give consent

Exclusion criteria

lack of symptoms persons unable to provide all 3 samples (for any reason) Onset of symptoms greater than 7 days

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026